These observations could be generalized that the “Non-TT” variant type indicates better survival, compared with “TT” variant type, in the patients with more advanced HCC (ascites, lower albumin level, microvascular invasion and higher AFP level). This evidence concerns the gene ALB and hepatocellular carcinoma.